Browsing Institute Director's Office by Issue Date
Now showing items 21-40 of 117
-
Understanding missed opportunities for more timely diagnosis of brain cancer – what can we learn from the BRACED qualitative interview study with adult glioma patients?
(2018-01-31)BACKGROUND BRACED (The BRAin Cancer Early Detection study) is a qualitative study of patient perspectives on factors affecting timely diagnosis of primary brain tumours. Patient, doctor and health-care system-related ... -
"I Thought I Was Controlling a Temporary Problem'': Exploring Patient Experience Along the Pathway to Diagnosis for Oesophageal and Gastric Cancer
(2018-03-15)Abstract from Qualitative Health Research Conference, 2017 -
Erratum: The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia
(2018-03-20)Correction to: British Journal of Cancer (2017) 117, 1459–1469; doi:https://doi.org/10.1038/bjc.2017.310; published online 19 September 2017 -
Cochrane systematic review of diagnostic accuracy of dermoscopy in comparison to visual inspection for the diagnosis of melanoma
(2018-07)Meeting abstract DS02 from British Association of Dermatologists 98th Annual Meeting, Edinburgh, U.K., 3–5 July 2018 -
Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126.
(2018-08)Chemical pollutant exposure is a risk factor contributing to the growing epidemic of non-alcoholic fatty liver disease (NAFLD) affecting human populations that consume a western diet. Although it is recognized that ... -
Development of cancer risk prediction models into tools for use in clinical settings
(2018-10)Meeting abstract P19.07C from 50th European-Society-of-Human-Genetics (ESHG) Conference -
Defining, Measuring and Preventing the Diagnosis of Cancer as an Emergency: A Critical Review of Current Evidence
(2018-10-01)Abstract from 2018 World Cancer Congress Abstracts -
Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.
(2019)Cutaneous squamous cell carcinomas are a common form of highly mutated keratinocyte skin cancers that are of particular concern in immunocompromised patients. Here we report on the efficacy of topically applied MS-275, a ... -
Azathioprine: friend or foe?
(2019-05) -
Symptom awareness measures for breast and cervical cancer in sub-Saharan Africa: A scoping review
(AOSIS, 2019-06-26)Background: In sub-Saharan Africa (SSA), breast cancer is the most commonly diagnosed cancer among women, while cervical cancer remains the leading cause of cancer death. Women often fail to recognise or misinterpret ... -
Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
(Cochrane Collaboration, 2019-07-01)BACKGROUND: Melanoma is one of the most aggressive forms of skin cancer, with the potential to metastasise to other parts of the body via the lymphatic system and the bloodstream. Melanoma accounts for a small percentage ...